PHARMORUBICIN

This brand name is authorized in Nigeria, New Zealand, Singapore, United Kingdom

Active ingredients

The drug PHARMORUBICIN contains one active pharmaceutical ingredient (API):

1 Epirubicin UNII 22966TX7J5 - EPIRUBICIN HYDROCHLORIDE

Epirubicin is a cytotoxic active antibiotic from the anthracycline group. The mechanism of action of epirubicin is related to its ability to bind to DNA. Cell culture studies have shown rapid cell penetration, localisation in the nucleus and inhibition of nucleic acid synthesis and mitosis. Read about Epirubicin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PHARMORUBICIN Solution for injection or infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01DB03	Epirubicin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 48532, 48535, 73212
Country: NG	Registered Drug Product Database	Identifier(s): B4-9273
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 4306
Country: SG	Health Sciences Authority	Identifier(s): 10098P